Kelly D. Watts

682 total citations
13 papers, 485 citations indexed

About

Kelly D. Watts is a scholar working on Physiology, Neurology and Neurology. According to data from OpenAlex, Kelly D. Watts has authored 13 papers receiving a total of 485 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Physiology, 4 papers in Neurology and 3 papers in Neurology. Recurrent topics in Kelly D. Watts's work include Alzheimer's disease research and treatments (8 papers), Dementia and Cognitive Impairment Research (3 papers) and Neuroinflammation and Neurodegeneration Mechanisms (3 papers). Kelly D. Watts is often cited by papers focused on Alzheimer's disease research and treatments (8 papers), Dementia and Cognitive Impairment Research (3 papers) and Neuroinflammation and Neurodegeneration Mechanisms (3 papers). Kelly D. Watts collaborates with scholars based in United States, United Kingdom and Netherlands. Kelly D. Watts's co-authors include William T. Hu, J. Christina Howell, Alexander Kollhoff, Monica W. Parker, Junjie Wu, Thomas S. Wingo, Deqiang Qiu, Allan I. Levey, James J. Lah and John Q. Trojanowski and has published in prestigious journals such as Neurology, Annals of Neurology and Frontiers in Aging Neuroscience.

In The Last Decade

Kelly D. Watts

12 papers receiving 483 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kelly D. Watts United States 11 265 203 110 104 91 13 485
Anette Hall Finland 14 199 0.8× 230 1.1× 105 1.0× 65 0.6× 67 0.7× 29 455
Brandalyn C. Riedel United States 6 220 0.8× 149 0.7× 90 0.8× 75 0.7× 35 0.4× 11 530
Nicholas J. Ashton United Kingdom 13 336 1.3× 248 1.2× 136 1.2× 89 0.9× 69 0.8× 55 539
Alexander Kollhoff United States 10 185 0.7× 153 0.8× 70 0.6× 102 1.0× 43 0.5× 22 442
Maria João Leitão Portugal 13 272 1.0× 256 1.3× 105 1.0× 76 0.7× 68 0.7× 22 449
José Antonio Allué Spain 7 427 1.6× 380 1.9× 118 1.1× 104 1.0× 42 0.5× 14 583
Isabel Hernández Spain 12 251 0.9× 177 0.9× 130 1.2× 67 0.6× 44 0.5× 23 461
Sally Hunter United Kingdom 14 426 1.6× 287 1.4× 145 1.3× 163 1.6× 143 1.6× 27 691
Małgorzata Chodakowska-Żebrowska Poland 13 263 1.0× 187 0.9× 184 1.7× 78 0.8× 77 0.8× 23 586
Andréa L. Benedet United Kingdom 11 453 1.7× 353 1.7× 148 1.3× 120 1.2× 76 0.8× 16 645

Countries citing papers authored by Kelly D. Watts

Since Specialization
Citations

This map shows the geographic impact of Kelly D. Watts's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kelly D. Watts with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kelly D. Watts more than expected).

Fields of papers citing papers by Kelly D. Watts

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kelly D. Watts. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kelly D. Watts. The network helps show where Kelly D. Watts may publish in the future.

Co-authorship network of co-authors of Kelly D. Watts

This figure shows the co-authorship network connecting the top 25 collaborators of Kelly D. Watts. A scholar is included among the top collaborators of Kelly D. Watts based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kelly D. Watts. Kelly D. Watts is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Schuster, Stephen J., Yubing Tong, Chao Wu, et al.. (2025). LBA4 | DEEP LEARNING‐BASED IMAGE ANALYSIS OF PRETREATMENT FDG‐PET/CT PREDICTS CAR T‐CELL TREATMENT OUTCOME AT 12 MONTHS. Hematological Oncology. 43(S3).
2.
Niedzwiecki, Megan M., Douglas I. Walker, J. Christina Howell, et al.. (2019). High‐resolution metabolomic profiling of Alzheimer’s disease in plasma. Annals of Clinical and Translational Neurology. 7(1). 36–45. 43 indexed citations
3.
Wharton, Whitney, Alexander Kollhoff, Umesh Gangishetti, et al.. (2019). Interleukin 9 alterations linked to alzheimer disease in african americans. Annals of Neurology. 86(3). 407–418. 40 indexed citations
4.
Campo, Marta del, Daniela Galimberti, Yolande A.L. Pijnenburg, et al.. (2018). Novel CSF biomarkers to discriminate FTLD and its pathological subtypes. Annals of Clinical and Translational Neurology. 5(10). 1163–1175. 23 indexed citations
5.
Gangishetti, Umesh, J. Christina Howell, Richard J. Perrin, et al.. (2018). Non-beta-amyloid/tau cerebrospinal fluid markers inform staging and progression in Alzheimer’s disease. Alzheimer s Research & Therapy. 10(1). 98–98. 21 indexed citations
6.
Howell, J. Christina, Kelly D. Watts, Monica W. Parker, et al.. (2017). Race modifies the relationship between cognition and Alzheimer’s disease cerebrospinal fluid biomarkers. Alzheimer s Research & Therapy. 9(1). 88–88. 140 indexed citations
7.
Bergquist, Sharon, Monica W. Parker, J. Christina Howell, et al.. (2017). Fear and Uncertainty Do Not Influence Reported Willingness to Undergo Lumbar Punctures in a U.S. Multi-Cultural Cohort. Frontiers in Aging Neuroscience. 9. 22–22. 15 indexed citations
8.
Hu, William T., Kelly D. Watts, Trung Nguyen, et al.. (2016). CSF complement 3 and factor H are staging biomarkers in Alzheimer’s disease. Acta Neuropathologica Communications. 4(1). 14–14. 35 indexed citations
9.
Howell, J. Christina, et al.. (2016). Research Lumbar Punctures among African Americans and Caucasians: Perception Predicts Experience. Frontiers in Aging Neuroscience. 8. 296–296. 33 indexed citations
10.
Hu, William T., Kelly D. Watts, Leslie M. Shaw, et al.. (2014). CSF beta‐amyloid 1–42 – what are we measuring in Alzheimer's disease?. Annals of Clinical and Translational Neurology. 2(2). 131–139. 32 indexed citations
11.
Hu, William T., Kelly D. Watts, James J. Lah, et al.. (2013). 2013 Emerging Science Abstracts. Neurology. 80(19). 2 indexed citations
12.
Hu, William T., Kelly D. Watts, Murray Grossman, et al.. (2013). Reduced CSF p-Tau 181 to Tau ratio is a biomarker for FTLD-TDP. Neurology. 81(22). 1945–1952. 88 indexed citations
13.
Watts, Kelly D., et al.. (2005). Septal co-infusions of glucose with a GABAB agonist impair memory. Neurobiology of Learning and Memory. 85(1). 66–70. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026